Horizon Discovery Group PLC (LON:HZD) is scheduled to release its earnings data on Monday, September 18th.

Shares of Horizon Discovery Group PLC (HZD) opened at 238.00 on Monday. The firm’s 50-day moving average is GBX 257.84 and its 200 day moving average is GBX 209.93. The firm’s market cap is GBX 226.68 million. Horizon Discovery Group PLC has a 52 week low of GBX 104.00 and a 52 week high of GBX 289.00.

ILLEGAL ACTIVITY NOTICE: “Horizon Discovery Group PLC (HZD) to Release Earnings on Monday” was first published by American Banking News and is owned by of American Banking News. If you are accessing this piece on another site, it was illegally copied and republished in violation of international copyright and trademark laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/09/11/horizon-discovery-group-plc-hzd-to-release-earnings-on-monday.html.

A number of analysts recently commented on the company. Numis Securities Ltd reaffirmed a “buy” rating and set a GBX 300 ($3.87) price objective on shares of Horizon Discovery Group PLC in a research note on Friday. N+1 Singer reaffirmed a “buy” rating on shares of Horizon Discovery Group PLC in a research note on Tuesday, May 30th. Beaufort Securities reaffirmed a “speculative buy” rating and set a GBX 200 ($2.58) price objective on shares of Horizon Discovery Group PLC in a research note on Wednesday, May 31st. Panmure Gordon reaffirmed a “buy” rating and set a GBX 205 ($2.65) price objective on shares of Horizon Discovery Group PLC in a research note on Monday, May 22nd. Finally, Shore Capital reaffirmed a “not rated” rating on shares of Horizon Discovery Group PLC in a research note on Wednesday, July 19th. Two investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. Horizon Discovery Group PLC presently has an average rating of “Buy” and an average price target of GBX 233.80 ($3.02).

Horizon Discovery Group PLC Company Profile

Horizon Discovery Group PLC is a gene editing company that designs and engineers genetically-modified cells, applying them in research and clinical applications to advance human health. The Company’s gene editing platform, able to alter almost any gene sequence, has generated a catalogue of over 23,000 cell and in vivo models that recapitulate the genetic anomalies found in diseases like cancer.

Receive News & Ratings for Horizon Discovery Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horizon Discovery Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.